Literature DB >> 18617513

The RING domain and first zinc finger of TRAF6 coordinate signaling by interleukin-1, lipopolysaccharide, and RANKL.

Betty Lamothe1, Alejandro D Campos, William K Webster, Ambily Gopinathan, Lana Hur, Bryant G Darnay.   

Abstract

TRAF6, a crucial adaptor molecule in innate and adaptive immunity, contains three distinct functional domains. The C-terminal TRAF domain facilitates oligomerization and sequence-specific interaction with receptors or other adaptor proteins. In conjunction with the dimeric E2 enzyme Ubc13-Uev1A, the N-terminal RING domain of TRAF6 functions as an E3 ubiquitin (Ub) ligase that facilitates its own site-specific ubiquitination through the generation of a Lys-63-linked poly-Ub chain. This modification does not cause its proteasomal degradation but rather serves as a scaffold to activate both the IKK and stress kinase pathways. Connecting the N-and C-terminal regions, the four internal zinc finger (ZF) motifs have yet to be functionally defined. In this study, we examined the role of the ZF domains in interleukin-1, lipopolysaccharide, and RANKL signaling by reconstitution of TRAF6-deficient cells with point mutations or deletions of these ZF motifs. Although ZF domains 2-4 are dispensable for activating IKK, p38, and JNK by interleukin-1 and lipopolysaccharide, the first ZF domain together with an intact RING domain of TRAF6 is essential for activating these pathways. Furthermore, TRAF6 autoubiquitination and its interaction with Ubc13 are dependent on ZF1 and an intact RING domain. Additionally, expression of TRAF6 lacking ZF2-4 in TRAF6-deficient monocytes rescues RANKL-mediated osteoclast differentiation and LPS-stimulated interleukin-6 production. These data provide evidence for the critical role of the Ub ligase activity of TRAF6, which is coordinated via the RING domain and ZF1 to supply the necessary elements in signaling by cytokines dependent upon TRAF6.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18617513      PMCID: PMC2529010          DOI: 10.1074/jbc.M802749200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

Review 1.  Role of TRAF6 in the immune system.

Authors:  Yongwon Choi
Journal:  Adv Exp Med Biol       Date:  2005       Impact factor: 2.622

2.  TRAF6 is a T cell-intrinsic negative regulator required for the maintenance of immune homeostasis.

Authors:  Carolyn G King; Takashi Kobayashi; Pedro J Cejas; Taesoo Kim; Kwiyeom Yoon; Gregory K Kim; Elise Chiffoleau; Somia P Hickman; Patrick T Walsh; Laurence A Turka; Yongwon Choi
Journal:  Nat Med       Date:  2006-07-20       Impact factor: 53.440

3.  Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice.

Authors:  A Naito; S Azuma; S Tanaka; T Miyazaki; S Takaki; K Takatsu; K Nakao; K Nakamura; M Katsuki; T Yamamoto; J Inoue
Journal:  Genes Cells       Date:  1999-06       Impact factor: 1.891

4.  Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of I kappa B kinase activation.

Authors:  Betty Lamothe; Arnaud Besse; Alejandro D Campos; William K Webster; Hao Wu; Bryant G Darnay
Journal:  J Biol Chem       Date:  2006-11-29       Impact factor: 5.157

5.  Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif.

Authors:  B G Darnay; J Ni; P A Moore; B B Aggarwal
Journal:  J Biol Chem       Date:  1999-03-19       Impact factor: 5.157

6.  TAK1-dependent signaling requires functional interaction with TAB2/TAB3.

Authors:  Arnaud Besse; Betty Lamothe; Alejandro D Campos; William K Webster; Upendra Maddineni; Su-Chang Lin; Hao Wu; Bryant G Darnay
Journal:  J Biol Chem       Date:  2006-12-08       Impact factor: 5.157

Review 7.  The role of TRAF6 in signal transduction and the immune response.

Authors:  Takashi Kobayashi; Matthew C Walsh; Yongwon Choi
Journal:  Microbes Infect       Date:  2004-11       Impact factor: 2.700

8.  Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase.

Authors:  B G Darnay; V Haridas; J Ni; P A Moore; B B Aggarwal
Journal:  J Biol Chem       Date:  1998-08-07       Impact factor: 5.157

9.  Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected].

Authors:  Chuan-Jin Wu; Dietrich B Conze; Tao Li; Srinivasa M Srinivasula; Jonathan D Ashwell
Journal:  Nat Cell Biol       Date:  2006-03-19       Impact factor: 28.824

10.  Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO.

Authors:  Chee-Kwee Ea; Li Deng; Zong-Ping Xia; Gabriel Pineda; Zhijian J Chen
Journal:  Mol Cell       Date:  2006-04-06       Impact factor: 17.970

View more
  50 in total

1.  Increased expression of TNF receptor-associated factor 6 after rat traumatic brain injury.

Authors:  Jian Chen; Xiujie Wu; Bai Shao; Wei Zhao; Wei Shi; Shuangwei Zhang; Lanchun Ni; Aiguo Shen
Journal:  Cell Mol Neurobiol       Date:  2010-11-12       Impact factor: 5.046

2.  Ubiquitin systems mark pathogen-containing vacuoles as targets for host defense by guanylate binding proteins.

Authors:  Arun K Haldar; Clémence Foltz; Ryan Finethy; Anthony S Piro; Eric M Feeley; Danielle M Pilla-Moffett; Masaki Komatsu; Eva-Maria Frickel; Jörn Coers
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-28       Impact factor: 11.205

Review 3.  CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes.

Authors:  S-C Sun
Journal:  Cell Death Differ       Date:  2010-01       Impact factor: 15.828

4.  Toll-like Receptor (TLR) Signaling Interacts with CREBH to Modulate High-density Lipoprotein (HDL) in Response to Bacterial Endotoxin.

Authors:  Aditya Dandekar; Yining Qiu; Hyunbae Kim; Jiemei Wang; Xia Hou; Xuebao Zhang; Ze Zheng; Roberto Mendez; Fu-Shin Yu; Ashok Kumar; Deyu Fang; Fei Sun; Kezhong Zhang
Journal:  J Biol Chem       Date:  2016-09-16       Impact factor: 5.157

5.  TRAF6 protein couples Toll-like receptor 4 signaling to Src family kinase activation and opening of paracellular pathway in human lung microvascular endothelia.

Authors:  Anguo Liu; Ping Gong; Sang W Hyun; Kent Z Q Wang; Elizabeth A Cates; Darren Perkins; Douglas D Bannerman; Adam C Puché; Vladimir Y Toshchakov; Shengyun Fang; Philip E Auron; Stefanie N Vogel; Simeon E Goldblum
Journal:  J Biol Chem       Date:  2012-03-23       Impact factor: 5.157

6.  Tumor necrosis factor receptor-associated factor 6 (TRAF6) and TGFβ-activated kinase 1 (TAK1) play essential roles in the C-type lectin receptor signaling in response to Candida albicans infection.

Authors:  Sara Gorjestani; Bryant G Darnay; Xin Lin
Journal:  J Biol Chem       Date:  2012-11-12       Impact factor: 5.157

7.  R753Q polymorphism inhibits Toll-like receptor (TLR) 2 tyrosine phosphorylation, dimerization with TLR6, and recruitment of myeloid differentiation primary response protein 88.

Authors:  Yanbao Xiong; Chang Song; Greg A Snyder; Eric J Sundberg; Andrei E Medvedev
Journal:  J Biol Chem       Date:  2012-09-19       Impact factor: 5.157

Review 8.  Tumor necrosis factor receptor-associated factor 6 as a nuclear factor kappa B-modulating therapeutic target in cardiovascular diseases: at the heart of it all.

Authors:  Muhammad Abdullah; Jessica M Berthiaume; Monte S Willis
Journal:  Transl Res       Date:  2017-11-07       Impact factor: 7.012

9.  Polyubiquitination events mediate polymethylmethacrylate (PMMA) particle activation of NF-kappaB pathway.

Authors:  Yasuhiro Yamanaka; Kannan Karuppaiah; Yousef Abu-Amer
Journal:  J Biol Chem       Date:  2011-05-12       Impact factor: 5.157

10.  TNF receptor-associated factor 6 interacts with ALS-linked misfolded superoxide dismutase 1 and promotes aggregation.

Authors:  Sabrina Semmler; Myriam Gagné; Pranav Garg; Sarah R Pickles; Charlotte Baudouin; Emeline Hamon-Keromen; Laurie Destroismaisons; Yousra Khalfallah; Mathilde Chaineau; Elise Caron; Andrew N Bayne; Jean-François Trempe; Neil R Cashman; Alexandra T Star; Arsalan S Haqqani; Thomas M Durcan; Elizabeth M Meiering; Janice Robertson; Nathalie Grandvaux; Steven S Plotkin; Heidi M McBride; Christine Vande Velde
Journal:  J Biol Chem       Date:  2020-02-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.